Todd Brady
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Mr. Todd R.
Brady, CFA MBA, is an Independent Director at Contineum Therapeutics, Inc. and a Director of Finance & Investments at Brace Pharmaceuticals, Inc. He is on the Board of Directors at Antiva Biosciences, Inc., HotSpot Therapeutics, Inc., Contineum Therapeutics, Inc. and Vero Biotech, Inc. Mr. Brady was previously employed as an Independent Director by Cocrystal Pharma, Inc., an Independent Director by Avidity Biosciences, Inc., and an Analyst by Interward Asset Management Ltd. He also served on the board at Navitor Pharmaceuticals, Inc., Miragen Therapeutics, Inc., Tyrogenex, Inc. and Therabron Therapeutics, Inc. He received his undergraduate degree from the University of Western Ontario and an MBA from The Schulich School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2019 |
Vero Biotech, Inc.
Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Directeur/Membre du Conseil | 01/07/2015 |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals invests in companies located in the United States and Brazil. The firm targets companies operating in the fields of bio-pharmaceuticals and biotech. It provides financing for early and late stage capital requirements. | Directeur Financier/CFO | 01/01/2014 |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Directeur/Membre du Conseil | 01/05/2020 |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. BiotechnologyHealth Technology Provides antiviral therapeutics | Directeur/Membre du Conseil | 01/07/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/01/2021 |
| COCRYSTAL PHARMA, INC. | Directeur/Membre du Conseil | 10/03/2020 |
| VIRIDIAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2017 |
Interward Asset Management Ltd.
Interward Asset Management Ltd. Investment ManagersFinance IAML focus on opportunities in North American small and mid-cap companies. The firm uses a rigorous fundamental analysis in achieving a consistent long-term investment performance. In making investment decisions, IAML’s investment process combines top-down sector identification and a strong bottom-up analysis. Their key selling criteria include setting price targets, monitoring performance against expectations, any change in fundamentals, identifying better alternatives and profit taking. | Analyst-Equity | 31/12/2008 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 14 |
|---|---|
Vero Biotech, Inc.
Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Health Technology |
Therabron Therapeutics, Inc.
Therabron Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. BiotechnologyHealth Technology Provides antiviral therapeutics | Health Technology |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Health Technology |
Avidity Biosciences, Inc.
Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Interward Asset Management Ltd.
Interward Asset Management Ltd. Investment ManagersFinance IAML focus on opportunities in North American small and mid-cap companies. The firm uses a rigorous fundamental analysis in achieving a consistent long-term investment performance. In making investment decisions, IAML’s investment process combines top-down sector identification and a strong bottom-up analysis. Their key selling criteria include setting price targets, monitoring performance against expectations, any change in fundamentals, identifying better alternatives and profit taking. | Finance |
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Offers drug discovery and development focused on small molecule kinase inhibitors | Health Technology |
The Schulich School of Business
The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for use in the treatment of human viral diseases | Health Technology |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals invests in companies located in the United States and Brazil. The firm targets companies operating in the fields of bio-pharmaceuticals and biotech. It provides financing for early and late stage capital requirements. | Finance |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Health Technology |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national